The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) provides a comprehensive update through its January 2026 newsletter, offering a roadmap for patients navigating this rare blood cancer. The publication features strategic leadership goals, such as new research agendas and record-breaking fundraising achievements aimed at finding a cure. Patients are encouraged to participate in the 2026 Global Patient Survey and utilize educational resources that clarify the manageable nature of the disease. Specialized support groups and affinity meetings are highlighted to foster community connections for diverse populations, including young adults, people of color, and the LGBTQ+ community. Additionally, the text emphasizes integrative wellness by promoting strength training, nutritional guidance regarding sugar, and stress management tools. Finally, the source reports on medical advancements, specifically the FDA clearance of a new targeted therapy for clinical trials.
The Waldenstrom's Weekly 1-23-26 - Podcast Edition
https://youtu.be/qUAm_jqdpCA
The Waldenstrom's Weekly 1-23-26 - PDF Version
https://conta.cc/4sSdqzF